• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  10/21/2004
Trade Name:  Concerta
Generic Name or Proper Name (*):  methylphenidate
Indications Studied:  ADHD
Label Changes Summary:  * Expanded labeling for 13-17 year olds including information on dose, PK parameters, and AE profile * Increase in age resulted in increased apparent oral clearance * For patients new to methylphenidate: higher maximum recommended dosage for adolescents compared to children 6-12 years of age * Data are inadequate to determine whether chronic use of stimulants in children may cause suppression of growth. Therefore, growth should be monitored during treatment * Safety and efficacy in children <6 years have not been established
Product Labeling:  Labeling  Opens a new window
Sponsor:  Alza
Pediatric Exclusivity Granted Date:  12/04/2003
Therapeutic Category:  CNS Stimulant